Cargando…

Biomarkers of diabetic kidney disease

Diabetic kidney disease (DKD) remains one of the leading causes of reduced lifespan in diabetes. The quest for both prognostic and surrogate endpoint biomarkers for advanced DKD and end-stage renal disease has received major investment and interest in recent years. However, at present no novel bioma...

Descripción completa

Detalles Bibliográficos
Autores principales:	Colhoun, Helen M., Marcovecchio, M. Loredana
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2018
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6448994/ https://www.ncbi.nlm.nih.gov/pubmed/29520581 http://dx.doi.org/10.1007/s00125-018-4567-5

Ejemplares similares

The molecular mechanisms underlying diabetic complications
por: Chiarelli, Francesco, et al.
Publicado: (2013)

Preventing Cardiovascular Complications in Type 1 Diabetes: The Need for a Lifetime Approach
por: Chiesa, Scott T., et al.
Publicado: (2021)

Research and young paediatricians
por: Marcovecchio, M Loredana
Publicado: (2014)

Update on statural growth and pubertal development in obese children
por: Leonibus, Chiara De, et al.
Publicado: (2012)

Novel Biomarkers of Diabetic Kidney Disease
por: Rico-Fontalvo, Jorge, et al.
Publicado: (2023)

Novel biomarkers for diabetic kidney disease
por: Jung, Chan-Young, et al.
Publicado: (2022)

New urinary biomarkers for diabetic kidney disease
por: Wang, Cheng, et al.
Publicado: (2013)

DKA management and outcomes
por: Chiarelli, Francesco, et al.
Publicado: (2013)

A1C Variability as an Independent Risk Factor for Microalbuminuria in Young People With Type 1 Diabetes
por: Marcovecchio, M. Loredana, et al.
Publicado: (2011)

Pathophysiologic Mechanisms and Potential Biomarkers in Diabetic Kidney Disease
por: Jung, Chan-Young, et al.
Publicado: (2022)

Circulating Biomarkers to Predict Diabetic Retinopathy in Patients with Diabetic Kidney Disease
por: , Jonny, et al.
Publicado: (2023)

Review of potential biomarkers of inflammation and kidney injury in diabetic kidney disease
por: Khanijou, Vuthi, et al.
Publicado: (2022)

Optimal Prandial Timing of Insulin Bolus in Youths with Type 1 Diabetes: A Systematic Review
por: Mozzillo, Enza, et al.
Publicado: (2022)

Novel biomarkers for prognosticating diabetic kidney disease progression
por: Swaminathan, Shilna Muttickal, et al.
Publicado: (2022)

Kidney function and renal resistive index in children with juvenile idiopathic arthritis
por: Cafarotti, Alessandro, et al.
Publicado: (2022)

Biomarker panels associated with progression of renal disease in type 1 diabetes
por: Colombo, Marco, et al.
Publicado: (2019)

Biomarker for early renal microvascular and diabetic kidney diseases
por: Futrakul, Narisa, et al.
Publicado: (2017)

Microvascular disease in diabetes and severe COVID-19 outcomes – Authors' reply
por: Colhoun, Helen M, et al.
Publicado: (2021)

Significance of Diabetic Kidney Disease Biomarkers in Predicting Metabolic-Associated Fatty Liver Disease
por: Bae, Jaehyun, et al.
Publicado: (2023)

Insulin Administration and Rate of Glucose Appearance in People With Type 1 Diabetes
por: Pennant, Mary E., et al.
Publicado: (2008)

Diabetic ketoacidosis with severe hypokalemia and persistent hypernatremia in an adolescent girl with COVID‐19 infection
por: Badawy, Mohammed Kamal, et al.
Publicado: (2022)

Potential for Novel Biomarkers in Diabetes-Associated Chronic Kidney Disease: Epigenome, Metabolome, and Gut Microbiome
por: Lecamwasam, Ashani, et al.
Publicado: (2020)

Insulin resistance in type 1 diabetes: what is ‘double diabetes’ and what are the risks?
por: Cleland, S. J., et al.
Publicado: (2013)

MicroRNAs: new biomarkers and promising therapeutic targets for diabetic kidney disease
por: do Nascimento, Linicene Rosa, et al.
Publicado: (2019)

The Role of Podocytes and Podocyte-Associated Biomarkers in Diagnosis and Treatment of Diabetic Kidney Disease
por: Kravets, Igor, et al.
Publicado: (2020)

Current updates on protein as biomarkers for diabetic kidney disease: a systematic review
por: Sauriasari, Rani, et al.
Publicado: (2021)

Urinary Peptidomic Biomarkers in Kidney Diseases
por: Sirolli, Vittorio, et al.
Publicado: (2019)

Response to Comment on Vistisen et al. A Validated Prediction Model for End-Stage Kidney Disease in Type 1 Diabetes. Diabetes Care 2021;44:901–907
por: Vistisen, Dorte, et al.
Publicado: (2021)

Circulating Tumor Necrosis Factor Receptors: A Potential Biomarker for the Progression of Diabetic Kidney Disease
por: Murakoshi, Maki, et al.
Publicado: (2020)

Serum kidney injury molecule 1 and β(2)-microglobulin perform as well as larger biomarker panels for prediction of rapid decline in renal function in type 2 diabetes
por: Colombo, Marco, et al.
Publicado: (2018)

Biomarkers of Kidney Tubule Disease and Risk of End-Stage Kidney Disease in Persons With Diabetes and CKD
por: Amatruda, Jonathan G., et al.
Publicado: (2022)

Cardiac Imaging Biomarkers in Chronic Kidney Disease
por: Valbuena-López, Silvia C., et al.
Publicado: (2023)

Osteopontin as a Biomarker in Chronic Kidney Disease
por: Sinha, Satyesh K., et al.
Publicado: (2023)

Management of Hypertension in Diabetic Kidney Disease
por: Colbert, Gates B., et al.
Publicado: (2023)

Editorial: Debates in Clinical Management in Pediatric Endocrinology
por: Marcovecchio, Maria Loredana, et al.
Publicado: (2021)

Genomic approaches in the search for molecular biomarkers in chronic kidney disease
por: Cañadas-Garre, M., et al.
Publicado: (2018)

Mitochondria in Diabetic Kidney Disease
por: Ahmad, Amna Ayesha, et al.
Publicado: (2021)

Endothelin receptor antagonists in kidney protection for diabetic kidney disease and beyond?
por: Chung, Edmund Y. M., et al.
Publicado: (2022)

Mitochondrial Contribution to Inflammation in Diabetic Kidney Disease
por: Mitrofanova, Alla, et al.
Publicado: (2022)

Emerging Biomarkers for Early Detection of Chronic Kidney Disease
por: Mizdrak, Maja, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_3dv8hjo2aeo82adq1m27f5oi4j